Hassanein Waleed H 4
4 · TransMedics Group, Inc. · Filed Jul 14, 2026
Research Summary
AI-generated summary of this filing
TransMedics (TMDX) CEO Waleed Hassanein Receives RSU & Option Award
What Happened Waleed H. Hassanein, President, CEO and director of TransMedics Group, Inc. (TMDX), received equity awards on July 10, 2026: 49,669 restricted stock units (RSUs) and an award covering 112,984 derivative shares. Both awards show an acquisition price of $0.00 (standard granted compensation); no cash was paid. The RSUs represent contingent rights to receive common stock on vesting, and the derivative award is subject to a multi-year vesting schedule.
Key Details
- Transaction date(s): July 10, 2026; Form 4 filed July 14, 2026 (reporting date vs. filing date noted in the filing). Transaction code: A (award/grant).
- Grants: 49,669 RSUs (acquisition price $0.00); 112,984 derivative-share award (acquisition price $0.00).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes of note:
- F1: The 49,669 RSUs each represent a contingent right to receive one share of common stock upon vesting.
- F3: The derivative/option award vests at 2.0833% of the total each month beginning April 10, 2026, and finishing April 10, 2030, subject to continued service.
- F2: Separately, the filing reflects a prior (exempt) transfer of 150,000 shares between trusts (a change in form of beneficial ownership under Rule 16a-13).
- Filing timeliness: Form filed July 14, 2026 reporting the July 10, 2026 transactions; the filing does not indicate a tardy designation in the disclosed excerpt.
Context These were grants (compensation awards), not open-market purchases or sales. RSUs and option-like awards are common executive compensation and vest over time, so they convert to actual shares only as vesting conditions are met. Such awards are routine for executives and do not by themselves indicate immediate buying or selling intent.
Insider Transaction Report
- Award
Common Stock
[F1]2026-07-10+49,669→ 171,093 total - Award
Stock Option (Right to Buy)
[F3]2026-07-10+112,984→ 112,984 totalExercise: $71.23Exp: 2036-07-10→ Common Stock (112,984 underlying)
- 345,009(indirect: By Trust)
Common Stock
[F2] - 150,000(indirect: By Trust)
Common Stock
[F2]
Footnotes (3)
- [F1]Consists of 49,669 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Reflects a prior transfer of 150,000 shares of the Issuer's common stock from the Waleed H. Hassanein Revocable Trust to the Hassanein 2026 Qualified Annuity Trust. The transfer constituted only a change in the form of beneficial ownership and was exempt under Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
- [F3]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.